Article
Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Blood - 30 May 2013
Li Yong, Gordon Michael W, Xu-Monette Zijun Y, Visco Carlo, Tzankov Alexander, Zou Dehui, Qiu Lugui, Montes-Moreno Santiago, Dybkaer Karen, Orazi Attilio, Zu Youli, Bhagat Govind, Richards Kristy L, Hsi Eric D, Choi William W L, van Krieken J Han, Huang Qin, Ai Weiyun, Ponzoni Maurilio, Ferreri Andrés J M, Winter Jane N, Go Ronald S, Piris Miguel A, Møller Michael B, Wu Lin, Wang Michael, Ramos Kenneth S, Medeiros L Jeffrey, Young Ken H
Abstract excerpt
We identified multiple single nucleotide variants (SNVs) in the TP53 3' untranslated region (3'UTR) in tumor specimens from 244 patients with diffuse large B-cell lymphoma (DLBCL). Patients carrying a wild-type TP53 coding sequence (CDS) and 1 or more 3'UTR SNVs had a better 5-year survival rate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.